| Next 10 |
Ad
ASMB News and Press Assembly Biosciences Inc.
News | Assembly Biosciences Inc. (NASDAQ:ASMB)
-
2024-11-27 15:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
2024-11-17 00:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
2024-11-08 00:14:53 ET More on Assembly Biosciences Seeking Alpha’s Quant Rating on Assembly Biosciences Historical earnings data for Assembly Biosciences Financial information for Assembly Biosciences Read the full article on Seeking Alpha For...
-
Positive Phase 1a interim data released for ABI-5366, a long-acting HSV helicase-primase inhibitor candidate for recurrent genital herpes, supporting potential for once-weekly and once-monthly oral dosing First participants dosed in Phase 1b trial evaluating ABI-5366 in individuals with r...
-
2024-10-11 11:17:07 ET More on SPDR S&P Biotech ETF: XBI Is Breaking Out And Likely To Outperform In The Near Term (Technical Analysis) Biotech and Retail ETFs have the highest implied call return, according to Goldman Biotech IPOs return as sector recovers after...
-
2024-10-05 00:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
2024-09-24 08:00:12 ET Salim Syed from Mizuho Securities issued a price target of $36.00 for ASMB on 2024-09-24 06:41:00. The adjusted price target was set to $36.00. At the time of the announcement, ASMB was trading at $16.26. The overall price target consensus is at $3...
-
– ABI-5366 was well-tolerated, with a favorable safety profile observed with exposure of up to 70 days – – Half-life of approximately 20 days supports once-weekly or once-monthly oral dosing; both dosing schedules will be explored in the Phase 1b portion of the stud...
-
2024-09-20 05:00:09 ET Dennis Ding from Jefferies issued a price target of $35.00 for ASMB on 2024-09-20 03:30:00. The adjusted price target was set to $35.00. At the time of the announcement, ASMB was trading at $18.5. ASMB currently trades -4.01% versus its 52 week hig...
-
2024-09-13 12:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Stock Information
Get ASMB Alerts
News, Short Squeeze, Breakout and More Instantly...
Assembly Biosciences Inc. Company Name:
ASMB Stock Symbol:
NASDAQ Market:
Assembly Biosciences Inc. Website:
Ad
-
2024-11-27 15:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
2024-11-17 00:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
Positive Phase 1a interim data released for ABI-5366, a long-acting HSV helicase-primase inhibitor candidate for recurrent genital herpes, supporting potential for once-weekly and once-monthly oral dosing First participants dosed in Phase 1b trial evaluating ABI-5366 in individuals with r...